Colchicine vs placebo or usual careSerious adverse events within 28 days · people with SARS‐CoV‐2 infection and asymptomatic or mild disease1 finding from 1 reviewColchicine for the treatment of COVID‐19 2021 · Cochrane Headline outcomes onlyno estimate extracted1 study · 4412 participantsModerate